Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins

Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins

US Patent 10662193 · Granted May 26, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for the treatment or alleviation of disorders associated with Tau aggr2025
Compounds for the treatment or alleviation of disorders associated with Tau aggr2025
Compounds for the treatment or alleviation of disorders associated with Tau aggr2025
Compounds for the treatment, alleviation or prevention of disorders associated w2023
Compounds for the treatment, alleviation or prevention of disorders associated w2023
Compounds for the treatment, alleviation or prevention of disorders associated w2023
Compounds for the treatment, alleviation or prevention of disorders associated w2023
Bicyclic compounds for diagnosis and therapy2023
S1P3 antagonists2022
Gamma-carboline compounds for the detection of Tau aggregates2022
Gamma-carboline compounds for the detection of Tau aggregates2022
Gamma-carboline compounds for the detection of Tau aggregates2022